FDA Clearance Tracker · K210327
First Sign Multi-Drug Test Dip Card, First Sign Multi-Drug Test Cup, First Sign Multi-Drug Screen Test Dip Card, First Sign Multi-Drug Screen Test Cup
Last checked: Nov 19, 2026Latest source record: Aug 12, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Aug 12, 2021
Substantially Equivalent
Time to decision
189 days
Received Feb 4, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K210327
- Device name
- First Sign Multi-Drug Test Dip Card, First Sign Multi-Drug Test Cup, First Sign Multi-Drug Screen Test Dip Card, First Sign Multi-Drug Screen Test Cup
- Applicant
- W.H.P.M., Inc.
- Applicant location
- Irwindale, CA
- Received
- Feb 4, 2021
- Decided
- Aug 12, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Propoxyphene, Over The Counter (QBF)
- Device class
- Class II
- Regulation
- 21 CFR 862.3700
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QBF (Test, Propoxyphene, Over The Counter).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K210327
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for W.H.P.M., Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K200754 · Decided Jun 2, 2022 · 801 days after receipt
Device type: Automated Occult Blood Analyzer (OOX) · Laboratory Medicine & Pathology
K171695 · Decided Feb 5, 2018 · 243 days after receipt
Device type: Test, Amphetamine, Over The Counter (NFT) · Laboratory Medicine & Pathology
K160793 · Decided Aug 17, 2016 · 147 days after receipt
Device type: Enzyme Immunoassay, Methadone (DJR) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.